Company Overview - Zoetis Inc. is a leading global animal health company focused on veterinary vaccines and medicines, operating in over 100 countries and serving veterinarians, livestock producers, and pet owners [1] Recent Performance - Over the past month, Zoetis's stock has increased by 0.013%, indicating a steady upward trend, while experiencing a decline of 3.23% in the last 10 days, which may present a strategic entry point for investors [2][6] Growth Potential - The company has a projected stock price increase of 21.28%, suggesting significant upside potential for investors, supported by its strong market position and fundamentals [3][6] Financial Health - Zoetis has a Piotroski Score of 8, reflecting strong financial stability and operational efficiency, which is crucial for long-term growth and investor confidence [4][6] Analyst Outlook - Analysts have set a target price of $181.67 for Zoetis, indicating optimism about the stock's future performance and aligning with the company's growth potential [5]